Literature DB >> 2672877

Determination of serum cholesterol by a modification of the isotope dilution mass spectrometric definitive method.

P Ellerbe, S Meiselman, L T Sniegoski, M J Welch, E White.   

Abstract

An isotope dilution mass spectrometric (ID/MS) method for cholesterol is described that uses capillary gas chromatography with cholesterol-13C3 as the labeled internal standard. Labeled and unlabeled cholesterol are converted to the trimethylsilyl ether. Combined capillary column gas chromatography and electron impact mass spectrometry are used to obtain the abundance ratio of the unlabeled and labeled [M+.] ions from the derivative. Quantitation is achieved by measurement of each sample between measurements of two standards whose unlabeled/labeled ratios bracket that of the sample. Seven pools were analyzed by this method: standard reference material (SRM) 1951, which consists of three frozen serum pools with low, medium, and high levels of cholesterol; SRM 1952, which consists of three freeze-dried serum pools with low, medium, and high levels of cholesterol; and SRM 909, a freeze-dried serum pool. The method is a modification of our original definitive method for cholesterol. The modified method uses much better chromatographic separations to assure specificity and a new method of implementing selected ion monitoring on a magnetic mass spectrometer to obtain high-precision measurements of ion intensity ratios on narrow gas chromatographic peaks. The modified method has a coefficient of variation (CV) of 0.22%, which is an improvement over the original method's CV of 0.36%. The measurements were found to be free of interference. The high precision and absence of bias qualify this method as a candidate definitive method.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2672877     DOI: 10.1021/ac00190a025

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  6 in total

1.  Total cholesterol performance of Abell-Levy-Brodie-Kendall reference measurement procedure: Certification of Japanese in-vitro diagnostic assay manufacturers through CDC's Cholesterol Reference Method Laboratory Network.

Authors:  Masakazu Nakamura; Hiroyasu Iso; Akihiko Kitamura; Hironori Imano; Masahiko Kiyama; Shinji Yokoyama; Yuzo Kayamori; Isao Koyama; Kunihiro Nishimura; Michikazu Nakai; Mahnaz Dasti; Hubert W Vesper; Tamio Teramoto; Yoshihiro Miyamoto
Journal:  Clin Chim Acta       Date:  2015-03-26       Impact factor: 3.786

Review 2.  Harmonization of Liquid Chromatography-Tandem Mass Spectrometry Protein Assays.

Authors:  Alan L Rockwood; Mark S Lowenthal; Cory Bystrom
Journal:  Clin Lab Med       Date:  2018-09       Impact factor: 1.935

3.  Certification of fat-soluble vitamins, carotenoids, and cholesterol in human serum: Standard Reference Material 968b.

Authors:  J B Thomas; M C Kline; S B Schiller; P M Ellerbe; L T Sniegoski; D L Duewer; K E Sharpless
Journal:  Anal Bioanal Chem       Date:  1996-08       Impact factor: 4.142

4.  Histochemical detection of GM1 ganglioside using cholera toxin-B subunit. Evaluation of critical factors optimal for in situ detection with special emphasis to acetone pre-extraction.

Authors:  T Petr; V Smíd; J Smídová; H Hůlková; M Jirkovská; M Elleder; L Muchová; L Vitek; F Smíd
Journal:  Eur J Histochem       Date:  2010-05-12       Impact factor: 3.188

Review 5.  Clinical Mass Spectrometry in the Bioinformatics Era: A Hitchhiker's Guide.

Authors:  Yeow-Kuan Chong; Chi-Chun Ho; Shui-Yee Leung; Susanna K P Lau; Patrick C Y Woo
Journal:  Comput Struct Biotechnol J       Date:  2018-08-28       Impact factor: 7.271

6.  From urban dust and marine sediment to Ginkgo biloba and human serum-a top ten list of Standard Reference Materials (SRMs).

Authors:  Stephen A Wise
Journal:  Anal Bioanal Chem       Date:  2021-07-21       Impact factor: 4.142

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.